Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.

Olsen JR, Oyan AM, Rostad K, Hellem MR, Liu J, Li L, Micklem DR, Haugen H, Lorens JB, Rotter V, Ke XS, Lin B, Kalland KH.

PLoS One. 2013 May 1;8(5):e62547. doi: 10.1371/journal.pone.0062547. Print 2013.

2.

ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.

Zhao W, Wang H, Han X, Ma J, Zhou Y, Chen Z, Zhou H, Xu H, Sun Z, Kong B, Fang H.

Tumour Biol. 2016 Aug;37(8):10621-32. doi: 10.1007/s13277-016-4921-5. Epub 2016 Feb 10.

PMID:
26864590
3.

The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205.

Tran MN, Choi W, Wszolek MF, Navai N, Lee IL, Nitti G, Wen S, Flores ER, Siefker-Radtke A, Czerniak B, Dinney C, Barton M, McConkey DJ.

J Biol Chem. 2013 Feb 1;288(5):3275-88. doi: 10.1074/jbc.M112.408104. Epub 2012 Dec 13.

4.

The p63 Gene Is Regulated by Grainyhead-like 2 (GRHL2) through Reciprocal Feedback and Determines the Epithelial Phenotype in Human Keratinocytes.

Mehrazarin S, Chen W, Oh JE, Liu ZX, Kang KL, Yi JK, Kim RH, Shin KH, Park NH, Kang MK.

J Biol Chem. 2015 Aug 7;290(32):19999-20008. doi: 10.1074/jbc.M115.659144. Epub 2015 Jun 17.

5.

Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.

Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Guío-Carrión A, Hasenfuss SC, Eger A, Müller M, Beug H, Wagner EF.

Cell Death Differ. 2015 Feb;22(2):336-50. doi: 10.1038/cdd.2014.157. Epub 2014 Oct 10.

6.

DeltaNp63α protein triggers epithelial-mesenchymal transition and confers stem cell properties in normal human keratinocytes.

Oh JE, Kim RH, Shin KH, Park NH, Kang MK.

J Biol Chem. 2011 Nov 4;286(44):38757-67. doi: 10.1074/jbc.M111.244939. Epub 2011 Aug 31. Erratum in: J Biol Chem. 2012 Apr 13;287(16):13049.

7.

ZEB1 limits adenoviral infectability by transcriptionally repressing the coxsackie virus and adenovirus receptor.

Lacher MD, Shiina M, Chang P, Keller D, Tiirikainen MI, Korn WM.

Mol Cancer. 2011 Jul 27;10:91. doi: 10.1186/1476-4598-10-91.

8.

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

Chua HL, Bhat-Nakshatri P, Clare SE, Morimiya A, Badve S, Nakshatri H.

Oncogene. 2007 Feb 1;26(5):711-24. Epub 2006 Jul 24.

PMID:
16862183
9.

Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.

J Biol Chem. 2012 Feb 17;287(8):5819-32. doi: 10.1074/jbc.M111.295964. Epub 2011 Dec 28.

10.

MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63α and promotes mesenchymal-to-epithelial transition.

DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ, DiRenzo J.

Cell Death Dis. 2013 Feb 28;4:e514. doi: 10.1038/cddis.2013.37.

11.

Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells.

Graham TR, Zhau HE, Odero-Marah VA, Osunkoya AO, Kimbro KS, Tighiouart M, Liu T, Simons JW, O'Regan RM.

Cancer Res. 2008 Apr 1;68(7):2479-88. doi: 10.1158/0008-5472.CAN-07-2559. Erratum in: Cancer Res. 2008 May 15;68(10):4012.

12.

Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.

Hugo HJ, Pereira L, Suryadinata R, Drabsch Y, Gonda TJ, Gunasinghe NP, Pinto C, Soo ET, van Denderen BJ, Hill P, Ramsay RG, Sarcevic B, Newgreen DF, Thompson EW.

Breast Cancer Res. 2013 Nov 27;15(6):R113. doi: 10.1186/bcr3580.

13.

ΔNp63α Transcriptionally Regulates the Expression of CTEN That Is Associated with Prostate Cell Adhesion.

Yang K, Wu WM, Chen YC, Lo SH, Liao YC.

PLoS One. 2016 Jan 19;11(1):e0147542. doi: 10.1371/journal.pone.0147542. eCollection 2016.

14.

Role of DeltaNp63gamma in epithelial to mesenchymal transition.

Lindsay J, McDade SS, Pickard A, McCloskey KD, McCance DJ.

J Biol Chem. 2011 Feb 4;286(5):3915-24. doi: 10.1074/jbc.M110.162511. Epub 2010 Dec 2.

15.

Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.

Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G.

Oncogene. 2014 Mar 6;33(10):1325-35. doi: 10.1038/onc.2013.53. Epub 2013 Mar 11.

PMID:
23474752
16.

Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.

Konradi S, Yasmin N, Haslwanter D, Weber M, Gesslbauer B, Sixt M, Strobl H.

Eur J Immunol. 2014 Feb;44(2):553-60. doi: 10.1002/eji.201343681. Epub 2013 Dec 2.

17.

Xihuang Pill () induces mesenchymal-epithelial transition and inhibits loss of apical-basal polarity in colorectal cancer cell through regulating ZEB1-SCRIB loop.

Wang M, Meng JY, He SF.

Chin J Integr Med. 2014 Oct;20(10):751-7. doi: 10.1007/s11655-014-1812-8. Epub 2014 May 6.

PMID:
24802235
18.

Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.

Toll A, Masferrer E, Hernández-Ruiz ME, Ferrandiz-Pulido C, Yébenes M, Jaka A, Tuneu A, Jucglà A, Gimeno J, Baró T, Casado B, Gandarillas A, Costa I, Mojal S, Peña R, de Herreros AG, García-Patos V, Pujol RM, Hernández-Muñoz I.

J Dermatol Sci. 2013 Nov;72(2):93-102. doi: 10.1016/j.jdermsci.2013.07.001. Epub 2013 Jul 15.

PMID:
23928229
19.

Anoxia/reoxygenation induces epithelial-mesenchymal transition in human colon cancer cell lines.

Okajima M, Kokura S, Ishikawa T, Mizushima K, Tsuchiya R, Matsuyama T, Adachi S, Okayama T, Sakamoto N, Kamada K, Katada K, Uchiyama K, Handa O, Takagi T, Yagi N, Naito Y, Yoshikawa T.

Oncol Rep. 2013 Jun;29(6):2311-7. doi: 10.3892/or.2013.2401. Epub 2013 Apr 10.

PMID:
23589103
20.

KDM5B histone demethylase controls epithelial-mesenchymal transition of cancer cells by regulating the expression of the microRNA-200 family.

Enkhbaatar Z, Terashima M, Oktyabri D, Tange S, Ishimura A, Yano S, Suzuki T.

Cell Cycle. 2013 Jul 1;12(13):2100-12. doi: 10.4161/cc.25142. Epub 2013 Jun 6.

Supplemental Content

Support Center